Citation Impact
Citing Papers
DiarrheagenicEscherichia coli
1998 Standout
Antiseptics and Disinfectants: Activity, Action, and Resistance
1999 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines
2008
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
Immunization of Mice With Vibrio cholerae Outer-Membrane Vesicles Protects Against Hyperinfectious Challenge and Blocks Transmission
2011
Enteric infections
1990
Preventing infectious disease with passive immunization
2000
A Rapid Test for Infectious and Inflammatory Enteritis
1994
Identification of genes involved in the switch between the smooth and rugose phenotypes ofVibrio cholerae
2003
Milk Immunoglobulin with Specific Activity against Purified Colonization Factor Antigens Can Protect against Oral Challenge with EnterotoxigenicEscherichia coli
1998
Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area
2000
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
2007 Standout
Biofilms: the matrix revisited
2004 Standout
Bactericidal effect of bovine normal and immune serum, colostrum and milk against Helicobacter pylori
1995
New strategies for using mucosal vaccination to achieve more effective immunization
1994
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
Plasmid addiction systems: perspectives and applications in biotechnology
2010
Mucosal immunity and vaccines
2005 Standout
Quorum sensing controls biofilm formation in Vibrio cholerae
2003
Challenge model for Helicobacter pylori infection in human volunteers
2004
Dengue: a continuing global threat
2010 Standout
Prevention and Suppression of Helicobacter felis Infection in Mice Using Colostral Preparation with Specific Antibodies
2003
Bacterial biofilms: from the Natural environment to infectious diseases
2004 Standout
Intensification of Antiretroviral Therapy With Raltegravir or Addition of Hyperimmune Bovine Colostrum in HIV-Infected Patients With Suboptimal CD4+ T-Cell Response: A Randomized Controlled Trial
2011
Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague
2010 StandoutNobel
Recombinant protein expression in Escherichia coli: advances and challenges
2014 Standout
Pathogenic Escherichia coli
2004 Standout
Physiological heterogeneity in biofilms
2008 Standout
Regulation of intestinal epithelial permeability by tight junctions
2012 Standout
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Characterization of hapR, a positive regulator of the Vibrio cholerae HA/protease gene hap, and its identification as a functional homologue of the Vibrio harveyi luxR gene
1997
Molecular analysis of rugosity in a Vibrio cholerae O1 El Tor phase variant
2004
HIV as the cause of AIDS
1996 StandoutNobel
Dengue
2012 Standout
Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions
2015 Standout
Filamentous phages linked to virulence of Vibrio cholerae
2003
Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC‐205/CD205‐positive mouse dendritic cells
2007 StandoutNobel
Vaccination against bubonic and pneumonic plague
2001
KDEL-Cargo Regulates Interactions between Proteins Involved in COPI Vesicle Traffic
2001 StandoutNobel
Lack of Prophylactic Efficacy of an Enteric‐Coated Bovine Hyperimmune Milk Product against EnterotoxigenicEscherichia coliChallenge Administered during a Standard Meal
1999
Dengue Vaccine Candidates in Development
2009
Human Immunodeficiency Virus Infection and AIDS in a Person with Negative Serology
1997 StandoutNobel
Candidate AIDS Vaccines
1995
Antifouling Coatings: Recent Developments in the Design of Surfaces That Prevent Fouling by Proteins, Bacteria, and Marine Organisms
2010 Standout
Leishmanization: Use of an old method for evaluation of candidate vaccines against leishmaniasis
2005
rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and Highly Infectious in Healthy Adult Volunteers
2005
Direct Detection of Bacterial Biofilms on the Middle-Ear Mucosa of Children With Chronic Otitis Media
2006 Standout
Silver nanoparticles as a new generation of antimicrobials
2008 Standout
Engineered Single-Domain Antibodies with High Protease Resistance and Thermal Stability
2011
Does the Antibacterial Activity of Silver Nanoparticles Depend on the Shape of the Nanoparticle? A Study of the Gram-Negative Bacterium Escherichia coli
2007 Standout
Isolation and Characterization of Rugose Form of Vibrio cholerae O139 Strain MO10
1999
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
The rbmBCDEF Gene Cluster Modulates Development of Rugose Colony Morphology and Biofilm Formation in Vibrio cholerae
2007
Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion
1996
QUORUM SENSING: Cell-to-Cell Communication in Bacteria
2005 Standout
Chemical Glycobiology
2001 StandoutScienceNobel
A Comprehensive Panel of Near-Full-Length Clones and Reference Sequences for Non-Subtype B Isolates of Human Immunodeficiency Virus Type 1
1998 StandoutNobel
Bacterial Biofilms: An Emerging Link to Disease Pathogenesis
2003 Standout
Heterologous antigen expression in Vibrio cholerae vector strains
1995
Cyclic‐diGMP signal transduction systems in Vibrio cholerae: modulation of rugosity and biofilm formation
2006
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Enterotoxigenic Escherichia coli in Developing Countries: Epidemiology, Microbiology, Clinical Features, Treatment, and Prevention
2005 Standout
BACTERIAL ENTERIC INFECTIONS AND VACCINE DEVELOPMENT
1992
Advances in leishmaniasis
2005 Standout
Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR
1996
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Cyclic di-GMP: the First 25 Years of a Universal Bacterial Second Messenger
2013 Standout
Resistance ofBacillusEndospores to Extreme Terrestrial and Extraterrestrial Environments
2000 Standout
Pathogenesis of human immunodeficiency virus infection
1993
Vibrio cholerae O1 El Tor: Identification of a gene cluster required for the rugose colony type, exopolysaccharide production, chlorine resistance, and biofilm formation
1999
CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain
1993
Cloning of a gene (zot) encoding a new toxin produced by Vibrio cholerae
1992
Association of Protease Activity in Vibrio cholerae Vaccine Strains with Decreases in Transcellular Epithelial Resistance of Polarized T84 Intestinal Epithelial Cells
2000
Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette.
1993
Wound Healing: A Cellular Perspective
2018 Standout
Cholera
2004
Smooth to rugose phase variation in Vibrio cholerae can be mediated by a single nucleotide change that targets c‐di‐GMP signalling pathway
2006
Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains
1997
Lipopolysaccharide Endotoxins
2002 Standout
Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunit
1995
Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin
1992
Microbial Biofilms: from Ecology to Molecular Genetics
2000 Standout
The Vibrio cholerae O139 O-antigen polysaccharide is essential for Ca 2+ -dependent biofilm development in sea water
2003
Characterization of Vibrio cholerae O1 El Tor galU and galE Mutants: Influence on Lipopolysaccharide Structure, Colonization, and Biofilm Formation
2001
The B-cell response in lymphoid tissue of mice immunized with various antigenic forms of the influenza virus hemagglutinin
1995 StandoutNobel
Epidemiology, Genetics, and Ecology of Toxigenic Vibrio cholerae
1998 Standout
Identification and Characterization of Cyclic Diguanylate Signaling Systems Controlling Rugosity in Vibrio cholerae
2008
Phages and the Evolution of Bacterial Pathogens: from Genomic Rearrangements to Lysogenic Conversion
2004 Standout
High-Frequency Rugose Exopolysaccharide Production by Vibrio cholerae
2002
Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections
1998 Standout
Bacterial Quorum-Sensing Network Architectures
2009 Standout
Biofilm Formation as Microbial Development
2000 Standout
Vibrio cholerae O1 Strain TSI-4 Produces the Exopolysaccharide Materials That Determine Colony Morphology, Stress Resistance, and Biofilm Formation
1998
Nanobodies: Natural Single-Domain Antibodies
2013 Standout
Antibody detection by agglutination–PCR (ADAP) enables early diagnosis of HIV infection by oral fluid analysis
2018 StandoutNobel
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Detection of Human Immunodeficiency Virus Antibodies in Oral Fluids
1998
Works of C O Tacket being referenced
Efficacy of Bovine Milk Immunoglobulin Concentrate in Preventing Illness after Shigella Flexneri Challenge
1992
Anti-CD4 Anti-Idiotype Antibodies in Volunteers Immunized with rgp 160 of HIV-1 or Infected with HIV-1
1992
SAFETY, IMMUNOGENICITY, AND EFFICACY OF RECOMBINANT LIVE ORAL CHOLERA VACCINES, CVD 103 AND CVD 103-HgR
1988
Vibrio cholerae 01 Can Assume a Chlorine-Resistant Rugose Survival Form that Is Virulent for Humans
1996
Volunteer Studies Investigating the Safety and Efficacy of Live Oral El Tor Vibrio cholerae O1 Vaccine Strain CVD 111
1997
Salivary antibodies to human immunodeficiency virus type 1 in a phase I AIDS vaccine trial.
1990
Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru
1997
Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system
1997
PHASE 1 STUDIES OF WALTER REED ARMY INSTITUTE OF RESEARCH CANDIDATE ATTENUATED DENGUE VACCINES: SELECTION OF SAFE AND IMMUNOGENIC MONOVALENT VACCINES
2003